Stryker completes acquisition of NICO Corporation to enhance Neurotechnology offerings for Tumor and Stroke care

Portage, MI, September 20, 2024 (PRnewswire) -- Stryker has acquired NICO Corporation, enhancing its portfolio of neurotechnology solutions for tumor resection and the treatment of intracerebral hemorrhage (ICH). This acquisition responds to the pressing need for improved treatment options in ICH, which affects millions and carries a high mortality risk. With NICO's innovative products, Stryker aims to provide minimally invasive solutions that will lead to better patient outcomes.

Read full article here.